Gujarat Themis Biosyn Q2 Results FY27: Revenue Up 17.87% YoY to Rs 49.92 Cr, Net Loss Rs 13.84 Cr

Gujarat Themis Biosyn Ltd (GUJTHEM) Q2 Results FY27 announced on 14 November 2026, covering the company's financial performance for the July to September quarter. The results date brought consolidated results with revenue of Rs 49.92 Cr and a PAT loss of Rs 13.84 Cr, so Gujarat Themis Biosyn Q2 Results FY27 show two lines moving in different directions. Both figures are measured against the same quarter of last year.

This Gujarat Themis Biosyn Q2 Results analysis covers the financial highlights, business drivers, outlook and risks. The results analysis starts with the Financial Highlights table, which places revenue and net profit beside the corresponding quarter of the previous year.

Click Here – Get Free Investment Predictions

Gujarat Themis Biosyn Q2 Results FY27: Financial Highlights

Metric	Q2 FY27 (Sep 26)	Q2 FY26 (Sep 25)	YoY Change
Revenue	Rs 49.92 Cr	Rs 42.35 Cr	+17.87% YoY
Net Profit (PAT)	Rs -13.84 Cr	Rs 14.27 Cr	-196.99% YoY

Source: company filing for Gujarat Themis Biosyn Q2 Results FY27, 14 November 2026. Figures in Rs Crore, Consolidated basis.

Key Takeaways from Gujarat Themis Biosyn Q2 Results: What Stands Out

• Revenue: Rs 49.92 Cr compared with Rs 42.35 Cr in the year-ago quarter, a YoY growth of 17.87% on the Consolidated basis.
• Net profit: A net loss of Rs 13.84 Cr against a net profit of Rs 14.27 Cr a year earlier, a 196.99% YoY decline.
• Direction: Revenue moved up while net profit moved down, which defines Gujarat Themis Biosyn Q2 Results FY27.
• Returns: Return on equity was 17.41% and return on capital employed was 18.16% in FY26, the latest full-year readings.
• Risk markers: Net profit margin stood at -27.7% against 33.7% a year ago, and debt was 0.56 times total assets in FY26.
• Next step: The performance analysis below sets the revenue gain beside the swing in profit.

Gujarat Themis Biosyn Q2 Results FY27: Performance Analysis

Gujarat Themis Biosyn recorded Consolidated revenue of Rs 49.92 Cr for July to September 2026, up 17.87% YoY from Rs 42.35 Cr. The company reported a net loss of Rs 13.84 Cr, compared with a net profit of Rs 14.27 Cr in the same quarter last year.

In Gujarat Themis Biosyn Q2 Results FY27, revenue added Rs 7.57 Cr over the year-ago quarter, while net profit moved by Rs 28.11 Cr in the opposite direction, from a profit to a loss. The results analysis shows that the revenue gain did not carry through to the bottom line.

The 196.99% YoY decline in net profit is the figure that stands apart in the Gujarat Themis Biosyn Q2 Results numbers. Readers will watch the next quarterly results for the direction of YoY growth in both lines, and the business factors listed next outline what the filing records.

Check the Univest Screener for live results data

Key Business Factors This Quarter

Revenue growth – The business factors in Gujarat Themis Biosyn Q2 Results FY27 begin with revenue, which grew 17.9% year on year to Rs 49.92 Cr in the latest quarter. This is the one reported line that moved higher.

Return on equity – Return on equity was 17.41% in FY26. This annual reading shows what the business earned on shareholder capital across the last full year, before the latest quarterly results arrived.

Return on capital employed – Return on capital employed was 18.16% in FY26. Alongside return on equity, it gives the full-year context in which the current quarter should be read.

FY27 Outlook After Gujarat Themis Biosyn Q2 Results

Full-year FY27 results for Gujarat Themis Biosyn will depend on the quarters still to be declared. Gujarat Themis Biosyn Q2 Results FY27 give the latest consolidated reading, with revenue at Rs 49.92 Cr and a net loss of Rs 13.84 Cr for July to September 2026.

A results analysis of later quarters will show how net profit moves against revenue from this point. Investors can follow each new filing through the Univest Screener, and the next section turns to the risks.

Key Risks to Watch After Gujarat Themis Biosyn Q2 Results FY27

Net Loss in the Quarter

The company reported a net loss of Rs 13.84 Cr in the latest quarter. This is the main item to follow, because the year-ago quarter showed a net profit of Rs 14.27 Cr.

Margin and Debt

Net profit margin narrowed to -27.7% from 33.7% in the comparison quarter, and debt is high at 0.56 times total assets in FY26. After Gujarat Themis Biosyn Q2 Results FY27, both measures stay in focus.

Volatile Quarterly Profit

Quarterly net profit has been volatile, ranging from Rs -13.84 Cr to Rs 14.27 Cr over the last 5 quarters. Such a wide range means the YoY growth in revenue may not signal profit on its own.

Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.

Conclusion

Gujarat Themis Biosyn Q2 Results FY27 show Consolidated revenue up 17.87% YoY to Rs 49.92 Cr and a net loss of Rs 13.84 Cr against a net profit of Rs 14.27 Cr. The quarterly results and the Gujarat Themis Biosyn Q2 Results data are available in the Univest app, and the consolidated results are best read with the margin and debt figures. Please consult a SEBI-registered advisor before acting.

Frequently Asked Questions on Gujarat Themis Biosyn Q2 Results FY27

What are Gujarat Themis Biosyn Q2 Results FY27?

Ans. Gujarat Themis Biosyn Q2 Results FY27 are the quarterly financial results of Gujarat Themis Biosyn for July to September 2026, showing Consolidated revenue of Rs 49.92 Cr and a net loss of Rs 13.84 Cr, as the Quick Answer explains.

What is the results date for Gujarat Themis Biosyn Q2 Results FY27?

Ans. The results date for Gujarat Themis Biosyn Q2 Results FY27 is 14 November 2026, which means the filing covers the July to September quarter and is compared with the same quarter of last year.

What revenue was reported in Gujarat Themis Biosyn Q2 Results FY27?

Ans. Gujarat Themis Biosyn reported revenue of Rs 49.92 Cr for the quarter, compared with Rs 42.35 Cr a year earlier, and the Financial Highlights table presents both figures side by side.

What net profit was reported in Gujarat Themis Biosyn Q2 Results FY27?

Ans. The company reported a net loss of Rs 13.84 Cr against a net profit of Rs 14.27 Cr in the year-ago quarter, as the Key Takeaways section shows in its second bullet.

How much YoY growth did revenue show in Gujarat Themis Biosyn Q2 Results FY27?

Ans. Revenue showed YoY growth of 17.87%, moving from Rs 42.35 Cr to Rs 49.92 Cr, while the Performance Analysis section shows that this added Rs 7.57 Cr over the year.

Did net profit rise or fall in Gujarat Themis Biosyn Q2 Results?

Ans. Net profit fell 196.99% YoY, moving from a profit of Rs 14.27 Cr to a loss of Rs 13.84 Cr, even as the Performance Analysis section records higher revenue.

What were the returns in Gujarat Themis Biosyn Q2 Results FY27?

Ans. Return on equity was 17.41% and return on capital employed was 18.16% in FY26, so the Key Business Factors section treats them as full-year context for the quarterly results.

Are Gujarat Themis Biosyn Q2 Results consolidated results or standalone results?

Ans. The figures are consolidated results, so every revenue and net profit number in this article reflects the Consolidated basis stated in the filing summary, and the Quick Answer repeats that basis.

What business factors shaped Gujarat Themis Biosyn Q2 Results FY27?

Ans. The business factors are 17.9% YoY revenue growth to Rs 49.92 Cr, a 17.41% return on equity and an 18.16% return on capital employed in FY26, as the Key Business Factors section sets out.

What are the key risks after Gujarat Themis Biosyn Q2 Results FY27?

Ans. The key risks are a net loss of Rs 13.84 Cr, a net profit margin of -27.7% against 33.7%, debt of 0.56 times total assets and volatile quarterly profit, as the Key Risks section explains.

What is the outlook after Gujarat Themis Biosyn Q2 Results?

Ans. Full-year FY27 results will depend on the quarters still to be declared, and the Outlook section notes that later quarterly results will show how revenue and net profit develop.

Where can I find the complete Gujarat Themis Biosyn Q2 Results FY27 data?

Ans. The complete data covers revenue and net profit in the Financial Highlights table above, and the Univest Screener lists later filings from Gujarat Themis Biosyn as well.